Who is sponsoring PADIT?

PADIT is sponsored by Population Health Research Institute.

What drugs are being tested in PADIT?

Interventions: Cefazolin, Bacitracin, Cefalexin, Cefazolin.

Last reviewed 2013-05-14 · How we verify

Phase III Pilot Study - A Simple Randomized Trial of Conventional Versus Multimodal Prevention of Arrhythmia Device Infection (PADIT)

NCT01002911 Phase 3 COMPLETED

The goal of the pilot study is to compare conventional antibiotic therapy to an aggressive antibiotic therapy plan for the prevention of arrhythmia device infection in high-risk patients undergoing arrhythmia device procedures. All antibiotics are approved for use and readily available.

Details

Lead sponsor	Population Health Research Institute
Phase	Phase 3
Status	COMPLETED
Enrolment	500
Start date	2009-12
Completion	2012-01

Conditions

Arrythmias

Interventions

Cefazolin, Bacitracin, Cefalexin
Cefazolin

Primary outcomes

Hospitalization attributed to device infection. — Patients will have one follow-up visit at 12 months or earlier should a primary outcome event occur.

Countries

Canada